Mitoxandrone 200 - Sandoz

Uses: metastatic breast cancer,acute myeloid leukemia, and non-Hodgkin's lymphoma. Also improve the survival of children suffering from first relapse of acute lymphoblastic leukaemia. Mitoxantrone and prednisone is approved as a second-line treatment for metastatic hormone-refractory prostate cancer. —also used to treat multiple sclerosis (MS), most notably the subset known as secondary progressive MS. Mitoxantrone will not cure multiple sclerosis, but is effective in slowing the progression of secondary progressive MS and extending the time between relapses in relapsing-remitting MS and progressive relapsing MS
Side effects: cause several adverse reactions of varying severity, such as nausea, vomiting, hair loss, heart damage, and immunosuppression.-Some side effects may have delayed onset. Cardiomyopathy is a particularly concerning effect as it is irreversible; regular monitoring with echocardiograms or MUGA scans is recommended for people taking mitoxantron.